Logo image
Insights into the structure–activity relationship of the anticancer compound ZJ-101, a derivative of marine natural product superstolide A: A critical role played by the conjugated trienyl lactone moiety
Journal article   Open access   Peer reviewed

Insights into the structure–activity relationship of the anticancer compound ZJ-101, a derivative of marine natural product superstolide A: A critical role played by the conjugated trienyl lactone moiety

Shan Qian, Aashay K. Shah, Sarah A. Head, Jun O. Liu and Zhendong Jin
Bioorganic & medicinal chemistry letters, Vol.26(15), pp.3411-3413
08/01/2016
DOI: 10.1016/j.bmcl.2016.06.057
PMCID: PMC5013146
PMID: 27374243
url
https://www.ncbi.nlm.nih.gov/pmc/articles/5013146View
Open Access

Abstract

[Display omitted] Compound ZJ-101, a structurally simplified analog of the marine natural product superstolide A, was previously developed in our laboratory. In the subsequent structure–activity relationship study, two new analogs, ZJ-105 and ZJ-106, were designed and synthesized to probe the importance of the conjugated trienyl lactone moiety of the molecule by replacing the C2–C3 double bond in ZJ-101 with a single bond and switching the geometry of the C4–C5 double bond in ZJ-101 from Z to E, respectively. Biological evaluation showed that ZJ-105 completely loses antiproliferative activity whereas ZJ-106 is significantly less active against cancer cells in vitro than ZJ-101, suggesting that the conjugated trienyl lactone moiety of the molecule is critical for its anticancer activity.
Anticancer agent Asymmetric synthesis Drug design Structure–activity relationship Superstolide A analog

Details

Metrics

Logo image